Oscar Health Reaffirms 2026 Outlook at Investor Conference
TipRanks (Mon, 2-Mar 7:14 AM ET)
Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025
Business Wire (Tue, 10-Feb 6:00 AM ET)
Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call
Business Wire (Tue, 13-Jan 6:00 AM ET)
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Globe Newswire (Fri, 12-Dec 9:59 AM ET)
Market Chameleon (Mon, 10-Nov 2:07 AM ET)
Market Chameleon (Tue, 4-Nov 4:23 AM ET)
Oscar Health Expands to 573 Counties, Unveils AI Agent and Menopause Plans for 2026
Market Chameleon (Mon, 20-Oct 3:10 AM ET)
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Oscar Health Class A trades on the NYSE stock market under the symbol OSCR.
As of March 5, 2026, OSCR stock price declined to $14.39 with 4,939,399 million shares trading.
OSCR has a beta of 1.09, meaning it tends to be more sensitive to market movements. OSCR has a correlation of 0.04 to the broad based SPY ETF.
OSCR has a market cap of $4.28 billion. This is considered a Mid Cap stock.
Last quarter Oscar Health Class A reported $3 billion in Revenue and -$1.24 earnings per share. This fell short of revenue expectation by $-353 million and missed earnings estimates by -$.35.
In the last 3 years, OSCR traded as high as $23.80 and as low as $3.23.
The top ETF exchange traded funds that OSCR belongs to (by Net Assets): VTI, AVUV, IWM, VB, VBK.
OSCR has underperformed the market in the last year with a return of -6.6%, while the SPY ETF gained +19.4%. In the last 3 month period, OSCR fell short of the market, returning -16.2%, while SPY returned -0.2%. However, in the most recent 2 weeks OSCR has outperformed the stock market by returning +5.0%, while SPY returned -0.7%.
OSCR support price is $14.39 and resistance is $15.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSCR shares will trade within this expected range on the day.